Why the study?
Many chronic heart failure patients become refractory to therapies, and confirmation of peritoneal dialysis benefits and identification of optimal candidates in the era of new therapies remains necessary.
Does peritoneal dialysis improve outcomes in patients with refractory congestive heart failure?
Does peritoneal dialysis improve outcomes in patients with refractory congestive heart failure?
Peritoneal dialysis offers a viable home-based ultrafiltration alternative for managing refractory congestive heart failure, with potential benefits on symptoms, hospitalizations, and quality of life.
Answers are grounded in this paper and cite their sources.
May support peritoneal dialysis in refractory HF; leaves open need for randomized confirmation.
Chronic heart failure is a growing problem. Despite progress in its management, many patients become refractory to therapies including diuretic resistance, major congestion, and worsening renal function. The only alternative to get rid of excess water and sodium is ultrafiltration, which can be achieved via hemodialysis or peritoneal dialysis (PD). The majority of studies have shown multiple benefits of PD as an improvement in functional class, a reduction in hospitalization leading to increased quality of life, and even a reduction in mortality. Being a home dialysis technique, it is more favorably accepted by patients. It remains necessary to confirm these potential positive outcomes and to identify patients who would benefit the most from this treatment in the era of new therapies available to date.
No takes yet. Share an insight, caveat, or question.
Azar et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: